This inventor holds 1 USPTO granted patent. Top assignee: Osi Pharmaceuticals, Inc.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: The Innovations of David Edward Smith
Introduction
David Edward Smith is a notable inventor based in SeaCliff, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of compounds that enhance the biosynthesis of erythropoietin. His work has implications for medical treatments and therapies.
Latest Patents
David Edward Smith holds a patent for "Tetracyclic compounds for enhancing biosynthesis of erythropoietin." This invention provides a compound in substantially pure form with a complex structure that includes various functional groups. The patent outlines the conditions under which these compounds can effectively modulate cellular expression of the mammalian gene encoding erythropoietin.
Career Highlights
Smith is associated with Osi Pharmaceuticals, Inc., where he has been involved in innovative research and development. His work has contributed to advancements in therapeutic compounds that can improve patient outcomes in various medical conditions.
Collaborations
Some of his notable coworkers include Jonathan G. Williams and David R. Houck. Their collaborative efforts have likely enhanced the research and development processes within their projects.
Conclusion
David Edward Smith's contributions to biotechnology through his patent and work at Osi Pharmaceuticals, Inc. highlight the importance of innovation in medical science. His research continues to pave the way for future advancements in therapeutic treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile